title: Patients with non-Jo-1 anti-RNA-synthetase autoantibodies have worse survival than Jo-1 positive patients.
authors: Baptiste
authors: B
authors: Hervier
authors: Hervé
authors: H
authors: Devilliers
authors: Olivier
authors: O
authors: Benveniste
mesh_terms: D000604:Amino Acyl-tRNA Synthetases / Q000276:immunology*; D000974:Antibodies, Antinuclear / Q000276:immunology*; D001226:Aspartate-tRNA Ligase / Q000276:immunology; D001323:Autoantibodies / Q000276:immunology*; D006032:Glycine-tRNA Ligase / Q000276:immunology; D006643:Histidine-tRNA Ligase / Q000276:immunology; D006801:Humans; D007533:Isoleucine-tRNA Ligase / Q000276:immunology; D009220:Myositis / Q000276:immunology / Q000401:mortality*; D012346:RNA, Transfer, Amino Acyl / Q000276:immunology
chemical_list: D000974:Antibodies, Antinuclear; D001323:Autoantibodies; C046750:Jo-1 antibody; D012346:RNA, Transfer, Amino Acyl; D000604:Amino Acyl-tRNA Synthetases; D001226:Aspartate-tRNA Ligase; D006032:Glycine-tRNA Ligase; D006643:Histidine-tRNA Ligase; C029194:asparaginyl-tRNA synthetase; D007533:Isoleucine-tRNA Ligase
keywords: Adult Onset Still's Disease; Amyloidosis; Analgesics